Register
Login:
Share:
Email Facebook Twitter


ETF Investing made simple; CEO of justETF explains why


Futura Medical Share Chat (FUM)



Share Price: 55.50Bid: 54.00Ask: 57.00Change: 0.00 (0.00%)No Movement on Futura Med.
Spread: 3.00Spread as %: 5.56%Open: 55.50High: 55.50Low: 55.50Yesterday’s Close: 55.50


Share Discussion for Futura Medical


Thread View

Please login or register to post a message on Share Chat.

Posts per page:


Whiterhino
Posts: 106
Off Topic
Opinion:No Opinion
Price:55.50
RE: March 23rd Preliminary Results
Mon 20:54
That's a great question. No reason to believe of course that the initial royalty agreement/payment hasn't been triggered yet, but you would think such a significant statement/event would have to be in there.
 
B2HS2L
Posts: 48
Research
Opinion:Strong Buy
Price:55.50
March 23rd Preliminary Results
Mon 17:36
I am looking for evidence of income from Royalties and Agreements in the March 23rd 2017 Prelim. results.

Below is an extract from the FUM Interim Results published 13.09.2016.

Bottom of Page 3 -

"Commercial manufacture of product for the launch of CSD500 in the first Middle East country, where
regulatory approval has already been granted, has already taken place with the launch expected later this
year.
The initial royalty payment has already been received for this and will be recognised upon launch.
We anticipate further launches of the product in other territories during 2017."

CSD500 recently launched in Saudi-Arabia, so I am assuming the royalty payments will be visible in the accounts.
Hopefully there will be info about amount of initial sales.

1) It will show the market FUM has a royalties income stream for the first time.

2) It might prompt the business press to articulate more often on FUM progress, and help to stabilise /improve the share price.

Lets hope the market likes the numbers.
GCCRa
Posts: 345
Off Topic
Opinion:Strong Buy
Price:54.00
James Barder
Fri 21:23
James Barder = Top Man.

You won't get many CEO's responding at all to shareholders, no-matter so quickly.

Well done Mr B and Chariot for asking the question.

Encouraging indeed. As you say, an announcement will come without warningSP will rocket with no time to respond. Best top up now I think !
Suark
Posts: 11
Off Topic
Opinion:No Opinion
Price:54.00
Chariot
Fri 18:11
Thanks for taking the time to post his reply, and well done to Mr. Barder for the info. Appreciate he can't be too specific.
Zwartkops
Posts: 104
Off Topic
Opinion:Strong Buy
Price:54.00
RE: Message from James Barder
Fri 14:35
Wow That answers so many questions...well done chariot...best news for months.
SuperRoty
Posts: 96
Off Topic
Opinion:Strong Buy
Price:54.00
RE: Message from James Barder
Fri 13:33
Great thanks Chariot for the update.

As I suspect this may take off without warning.
Chariot
Posts: 135
Off Topic
Opinion:No Opinion
Price:54.00
Message from James Barder
Fri 13:20
I wrote to FUM this morning asking why there is not much product launch or promotions of CSD 500 condoms though they have 8 licenses covering almost everywhere, within an hour James Barder replied me:

"In respect of your concerns over other CSD500 launches. We are actively working on all these launches however in a number of instances, for example China and South Korea, this still requires regulatory approval. In EU territories launch plans are progressing and we will update shareholders as soon as we can however there are considerable commercial sensitivities here and our partners understandably do not want us to flag their intentions to potential competitors ahead of launch.
Regards
James Barder
CEO
Futura Medical plc
handybrownone
Posts: 418
Off Topic
Opinion:No Opinion
Price:54.00
RE: Time and money
Thu 17:10
PE and pharma is the kiss of death - Valeant - Concordia - just left one pharma where PE came in. Stada are not going to buy this
Leveraged
Posts: 218
Off Topic
Opinion:No Opinion
Price:55.25
RE: Time and money
Thu 10:53
I suspect the private equity buyers of Stada will want more then just the recent UK licensing deal on Futura's pain gel in their "ambitious plans". Med2002 would also "boost" sales

https://www.bloomberg.com/news/articles/2017-02-12/drugmaker-stada-said-to-get-takeover-offers-from-advent-cinven

The drugmaker, which sells copies of medicines such as Viagra, has ambitious plans to boost revenue to 2.6 billion euros by 2019, up 23 percent from 2015, as both its branded medicines and cheaper copycat drugs expand sales.
Chariot
Posts: 135
Off Topic
Opinion:No Opinion
Price:56.00
Time and money
15 Feb '17
If you have time and money like me, I continue to buy and wait. But if you lack either of them, don't buy it because it will NOT be a get-rich-quick game.




Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk






Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.